Newsletters

Samsung’s quiet CardioBand FDA clearance. HealthXL’s evidence report.

8.08.19

4 min. Read

CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.

8.01.19

5 min. Read

The case against Proteus-Otsuka’s digital med. AliveCor’s 6th CEO

7.25.19

4 min. Read

FDA Pre-Cert tested with Pear insomnia DTx.

7.18.19

7 min. Read

Germany passes DTx formulary, payment law. Outcomes over Exits?

7.11.19

6 min. Read

Livongo clients mostly small commercial pilots? FDA easing.

7.02.19

6 min. Read

Omada’s strategy. Boehringer invests in myopia DTx.

6.27.19

6 min. Read

Digital health formulary wars heat up. $40M price tag for a digital drug.

6.20.19

7 min. Read

Express Scripts talks but CVS launches. India’s 4,800 health startups.

6.13.19

4 min. Read

Virta Health study. FDA-cleared algorithms. Arthritis DTx.

6.06.19

6 min. Read